Approaches to the Futures of Research (Based on the Conference Keynote, British Association of Dramatherapists Conference 2011, Measure for Measures, Researching, Re-Viewing and Re-Framing Dramatherapy in Practice)
Dramatherapy · 2012-07 · 34 (2) · 63-82
DOI: 10.1080/02630672.2012.704189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dramatherapy, online erschienen am 01.07.2012. Verfasst von Phil Jones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
This article, delivered in two parts, identifies and examines factors affecting the development of dramatherapy research. Drawing on qualitative research with Dramatherapists in a number of countries, it identifies three related challenges as a way of responding to the question, ‘What is the next developmental phase of dramatherapy research?’ The three challenges are: ‘impact’; ‘reviewing dramatherapy's relationship with qualitative and quantitative methodologies’; and ‘in depth: increasing the field's research capacity’.
Zitieren
APA
Jones, P. (2012). Approaches to the Futures of Research (Based on the Conference Keynote, British Association of Dramatherapists Conference 2011, Measure for Measures, Researching, Re-Viewing and Re-Framing Dramatherapy in Practice). Dramatherapy, 34(2), 63-82. https://doi.org/10.1080/02630672.2012.704189
Vancouver
Jones P. Approaches to the Futures of Research (Based on the Conference Keynote, British Association of Dramatherapists Conference 2011, Measure for Measures, Researching, Re-Viewing and Re-Framing Dramatherapy in Practice). Dramatherapy. 2012;34(2):63-82. doi:10.1080/02630672.2012.704189
BibTeX
@article{Jones2012,
author = {Jones, Phil},
title = {Approaches to the Futures of Research (Based on the Conference Keynote, British Association of Dramatherapists Conference 2011, Measure for Measures, Researching, Re-Viewing and Re-Framing Dramatherapy in Practice)},
journal = {Dramatherapy},
year = {2012},
volume = {34},
number = {2},
pages = {63--82},
doi = {10.1080/02630672.2012.704189}
}
EUVIMED